Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 1283 citations
Electronic publication date
October 15, 1994

View on Pubmed.gov 7943121 | View on doi.org 10.1016/s0002-9...

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

Search for publications in this journal Am J Ophthalmol - 118(4):445-50

Abstract

The vitreous levels of the angiogenic polypeptide vascular endothelial growth factor (also known as vascular permeability factor) were measured and compared in eyes with and without proliferative diabetic retinopathy. Undiluted vitreous samples from 20 eyes were collected at the time of vitrectomy, and vascular endothelial growth factor levels were determined by using a time-resolved immunofluorometric assay. Vitreous vascular endothelial growth factor levels were significantly higher in eyes with proliferative diabetic retinopathy than in eyes without proliferative diabetic retinopathy (P = .006; Wilcoxon Rank Sum Test). The median vitreous concentration in the eyes with proliferative diabetic retinopathy was 29.1 pM and exceeded the known concentration required for the maximal proliferation of vascular endothelial cells in vitro. These data are consistent with vascular endothelial growth factor serving as a physiologically relevant angiogenic factor in proliferative diabetic retinopathy.

References

No references provided.

Cited by 1283 citations (total)

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Electronic publication date January 1, 1995

Search for publications in this journal Mol Med

D T Shima [...] P A D'Amore et al.

BACKGROUND

New vessel growth is often associated with ischemia, and hypoxic tissue has been identified as a potential source of angiogenic...

Comparative Study Journal Article

Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.

Electronic publication date April 25, 2009

Search for publications in this journal Graefes Arch Clin Exp Ophthalmol

Philip Maier [...] Hansjürgen T Agostini et al.

BACKGROUND

Retinal neovascularisation occurs under the influence of angiogenic factors that are induced by hypoxia, like vascular endothelial growth factor (VEGF),...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances